Patent opinions from the Eastern District of Texas and the U.S. Court of Appeals for the Federal Circuit

Weekly Digest
Fed. Cir.

Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA, Inc., No. 16-1284 (Fed. Cir. May 1, 2017)

Errata Correction sheet to a previously issued opinion
Court
U.S. Court of Appeals for the Federal Circuit
Case No.
No. 16-1284
Also Docketed
No. 16-1787 (consolidated; same document)
Decided
May 1, 2017
Judge
Document
Errata
Length
1 page

United States Court of Appeals

for the Federal Circuit

July 31, 2017

ERRATA

Appeal Nos. 2016-1284, 2016-1787 HELSINN HEALTHCARE S.A.,

Plaintiff-Appellee

v.

TEVA PHARMACEUTICALS USA, INC., TEVA

PHARMACEUTICAL INDUSTRIES, LTD.,

Defendants-Appellants Decided: May 1, 2017 Precedential Opinion

Please make the following change: On page 27, change “under § 102(b)” to “under § 102.”

Text extracted from the official PDF and reflowed for reading. It is not a certified transcript — the PDF linked above is the authoritative document.

Analysis is coming soon.

A plain-English account of the issues, facts and holding, written by Patent Case Watch. The opinion itself — its full text, its PDF and everything else on this page — stays free to read for everyone, always.

Cite this opinion

Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA, Inc., No. 16-1284 (Fed. Cir. May 1, 2017).

govinfo ID
USCOURTS-ca13-16-01284-1
Permalink
https://patentcasewatch.com/opinions/USCOURTS-ca13-16-01284-1

No reporter citation is shown because the official source does not supply one; none is inferred here. Check the opinion and a citator before relying on this form.